Need for Cardiovascular Risk Reduction in Persons With Serious Mental Illness: Design of a Comprehensive Intervention

Frontiers in Psychiatry
Arlene T DalcinGail L Daumit

Abstract

Persons with serious mental illness (SMI) comprise a high-risk group for cardiovascular disease (CVD)-related mortality with rates at least twice those of the overall US. Potentially modifiable CVD risk behaviors (tobacco smoking, obesity, physical inactivity, unhealthy diet) and risk factors (hypertension, diabetes, dyslipidemia) are all markedly elevated in persons with SMI. Evaluations of programs implementing integrated medical care into specialty mental health settings have not shown meaningful effects on CVD risk factor reduction. Rigorously tested, innovative interventions are needed to address the large burden of CVD risk in populations with SMI. In this article, we describe the design of a comprehensive 18-month intervention to decrease CVD risk that we are studying in a randomized clinical trial in a community mental health organization with psychiatric rehabilitation programs. The individual-level intervention incorporated health behavior coaching and care coordination/care management to address all seven CVD risk behaviors and risk factors, and is delivered by a health coach and nurse. If successful, the intervention could be adopted within current integrated care models and significantly improve the physical health...Continue Reading

References

Jan 1, 1992·Health Affairs·W A Anthony
Dec 1, 1991·Journal of Behavior Therapy and Experimental Psychiatry·A A MendittoN C Beck
Jan 1, 1991·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·A RimmermanI Klein
Apr 1, 1995·Psychiatric Services : a Journal of the American Psychiatric Association·W A AnthonyR R Davies
Feb 7, 1998·Harvard Review of Psychiatry·K T MueserG R Bond
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·S Brown
Aug 5, 1997·American Journal of Health Promotion : AJHP·J O Prochaska, W F Velicer
May 20, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·M OlfsonJ Walkup
Jul 23, 1999·Schizophrenia Bulletin·M F Green, K H Nuechterlein
Oct 27, 1999·The Journal of Nervous and Mental Disease·A J SwansonK R Cohen
Sep 9, 2000·Schizophrenia Research·U OsbyP Sparén
Jan 6, 2001·Family Process·W J Gingerich, S Eisengart
May 2, 2001·The Cochrane Database of Systematic Reviews·C M RendersW J Assendelft
Apr 25, 2001·Community Mental Health Journal·P W CorriganE P Holmes
Oct 5, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·Kim T MueserMarvin I Herz
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Jun 23, 2004·Lancet·Kim T Mueser, Susan R McGurk
May 7, 2005·Journal of Clinical Psychopharmacology·A Eden EvinsNancy A Rigotti
May 12, 2005·Schizophrenia Research·Faith B DickersonLisa D Green-Paden
Jan 26, 2006·Hypertension·Lawrence J AppelUNKNOWN American Heart Association
May 11, 2006·Health Affairs·Marcela Horvitz-LennonHarold Alan Pincus
May 24, 2006·Journal of Substance Abuse Treatment·Stacey C Sigmon, Stephen T Higgins
Nov 28, 2006·The American Journal of Cardiology·William L HaskellJeff Myll
May 4, 2007·The Journal of Clinical Psychiatry·Benjamin G Druss, John W Newcomer
Oct 18, 2007·JAMA : the Journal of the American Medical Association·John W Newcomer, Charles H Hennekens
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Nov 22, 2008·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Douglas ZiedonisWilliam T Riley
Mar 17, 2009·American Journal of Preventive Medicine·David B AllisonJonathan E Alpert
Jun 26, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·P KnektO Lindfors
Dec 4, 2009·Schizophrenia Bulletin·Robert W BuchananUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Jan 22, 2010·Circulation·Donald M Lloyd-JonesUNKNOWN American Heart Association Strategic Planning Task Force and Statistics Committee
Mar 9, 2010·Psychiatry Research·Gail L DaumitDonald M Steinwachs
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Angela SchedlbauerTom Fahey
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Liam G GlynnTom Fahey
May 28, 2010·International Review of Psychiatry·Dan I LubmanDavid J Castle
Oct 15, 2010·Journal of Psychopharmacology·David Lawrence, Stephen Kisely
Dec 31, 2010·The New England Journal of Medicine·Wayne J KatonDavid McCulloch
Nov 22, 2011·The Psychiatric Clinics of North America·Meghan L ButrynThomas A Wadden

❮ Previous
Next ❯

Citations

May 20, 2020·Current Opinion in Psychiatry·Uta GühneThomas Becker

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

IDEAL

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.